The oncogene BRAFV600E is associated with a high risk of recurrence and less differentiated papillary thyroid carcinoma due to the impairment of Na+/I− targeting to the membraneGarcilaso Riesco‐Eizaguirre, Pilar Santisteban|Endocrine Related Cancer|2006Cited by 367